A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Researchers from the University of Illinois have identified a key process coordinating liver maturation and polyploidization, ...

Cannovation Clinical Research Partners Psychedelic Division We are pleased to announce the new changes within our organization as of ...

Long-term partnerships between banks and fintechs are the real future of financial services. Pharmaceutical firms' ...

I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of ...

NIH has an historic opportunity to transform post-viral illness research by bringing ME/CFS into its long Covid RECOVER ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the significance of triple-negative breast cancer ...

AI was a key theme at OCT Medical Devices 2025, yet human sensibility appears to be the true differentiator in clinical trial ...

Earlier phases of the trial showed promising results, with a single 25mg dose of COMP360 psilocybin, combined with psychological support, significantly reducing depressive symptoms after three weeks, ...

Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current ...